.jpg?format=webp&width=780)
A study involving whole-genome sequencing of over 7,800 individuals with cystic fibrosis (CF) has identified genetic modifiers associated with the severity of lung disease in CF patients. The researchers analyzed approximately 15.9 million genetic variants and conducted pathway analyses to discover genes involved in organ development, potentially influencing lung repair and dysanapsis. The study confirmed previous genome-wide association findings and identified multilocus effects at specific genetic loci. These findings provide valuable genetic information for further mechanistic studies and the development of new therapies for CF lung disease.
Like
Save
Share